NRGN Stock Quote - stock news and information

NEUROGEN

(NSDQ: NRGN)Add to My Watchlist

Detailed Quote

News

Last Price	0.18 ( 5:20 PM EST)
Change (%)	+0.01 (+5.88%)
Volume	61,221
Open	0.17
Previous Close	0.17
Day High	0.18
Day Low	0.17
Bid	0.17 x 96900
Ask	0.18 x 1000

Intraday

3 Month

6 Month

1 Year

Average Volume	546,094
Shares Outstanding	69.04M
Market Cap	12.4M
Year High	999.99
Year Low	0.06
Earnings Per Share	-0.28
P/E Ratio	-0.6
Dividend	N/A
Yield	N/A

Symbol	Last	Change (%)
PTXT	0.43	+0.00 (+0.00)
FNET	1.68	+0.40 (+31.25%)
VLCA-M	0.93	+0.00 (+0.00)
ESYS	4.10	+0.03 (+0.74%)
MAI	1.46	+0.17 (+12.90%)
CIRC	0.01	+0.00 (+11.11%)
IDC	0.23	+0.00 (+0.00)
GID	10.00	+0.00 (+0.00)

Fri, Nov 20, 2009
	Ebitda News Releases Ebitda Results for Neurogen - StockTrendNews.com e...
Wed, Nov 18, 2009
	Neurogen's Cash Flow now available from CFFO_NEWS - StockTrendNews.com c...
	Free Cash Flow for Neurogen - now available via Free-Cash-News - StockTrendNews.com f...
	Stockdiagnostics Releases Most Recent OPS Ranking for Neurogen - StockTrendNews.com o...
Mon, Aug 24, 2009
	Ligand Pharmaceuticals (LGND) to Acquire Neurogen (NRGN) Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4896102 for the full story. - StreetInsider
More News

Fri, Nov 06, 2009
	Neurogen Corporation Announces Third Quarter 2009 Financial Results and Updates Operations - Business Wire
Wed, Nov 04, 2009
	Neurogen Corporation Announces Webcast of Third Quarter 2009 Financial Results on November 6 - Business Wire
Wed, Sep 09, 2009
	Ligand Presents to Investors at Thomas Weisel Partners Healthcare Conference - Business Wire
Mon, Aug 24, 2009
	Levi & Korsinsky LLP Investigates Board of Neurogen Corporation - GlobeNewswire
	Ligand to Acquire Neurogen for Stock and Contingent Value Rights - Business Wire
More Press Releases

Fri, Nov 06, 2009
	RxNews Recap for Wednesday 11-04-09 Biotech investors interested in seeing more details about these companies and a full list of their related stories can do so by typing the stock ticker symbol into the Stock Quotes box on the right side of the page. Lannett Company, Inc. (NYSE:LCI), a manufacturer of generic pharmaceuticals, announced the company will release its fiscal 2010 first-quarter financial results on Monday, November 9, 2009. Catalyst Health Solutions, Inc. (NASDAQ:CHSI), a pharmacy benefit management company, announced its financial results for the third quarter ended September 30, 2009. SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced Mohammad Azab, M.D., Chief Medical Officer, will present at the Merriman Curhan Ford 6th Annual Investor Summit on Tuesday November 10, 2009 in New York. Unigene Laboratories, Inc. (OTC:UGNE) will release financial results for the quarter ended September 30, 2009, after the market closes on Monday, November 9, 2009. Emisphere Technologies, Inc. (OTC:EMIS) announced management will host a conference call to discuss the Company’s financial and operational results for the third quarter ended September 30, 2009 on Monday, November 9, 2009 at 10:00 AM EST. BioClinica™, Inc. (NASDAQ:BIOC), a global provider of clinical trial services, announced its financial results for the quarter and nine months ended September 30, 2009. Universal Detection Technology (OTC:UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats, announced it is expanding its product catalogue to include a consumer-ready kit for the detection of black mold. Emdeon® (NYSE:EM), a leading provider of healthcare revenue and payment cycle management solutions, announced its eRx Network® will provide real-time electronic billing solutions to retail pharmacies for the nation's top 25 medical payers in light of the dramatic increase in H1N1 vaccinations being administered by pharmacies. Phase Forward (NASDAQ:PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its senior vice president and chief financial officer, Chris Menard, and senior vice president of integration and product strategy, Martin Young, will present at the 18th Annual Credit Suisse Healthcare Conference at the Arizona Biltmore Hotel in Phoenix, Arizona. Medidata Solutions (NASDAQ:MDSO), a leading global provider of hosted clinical development solutions, announced a multi-year contract extension with Shire plc (NASDAQ:SHPGY) for use of Medidata Grants Manager™ and CRO Contractor™ benchmarking and analysis tools for investigator site and contract research organization (CRO) trial budget planning and forecasting. Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing a novel T-cell therapy for multiple sclerosis (MS), reported financial results for the quarter ended September 30, 2009, and provided details on further developments. AcuMedSpa Holdings, Inc. (OTC:AMSZ) is pleased to announce that it has reached an agreement with Santa Barbara Medical Innovations (SBMI) to become a preferred provider of the popular Zerona protocol which is a proven, non-invasive cold laser solution for unwanted body fat as well as for body slimming and contouring. Zerona has been featured in dozens of magazines and on TV shows such as "Rachael Ray," "Extra" and "The Doctors." Advanced Life Sciences Holdings, Inc. (OTC:ADLS), announced it will host a conference call and webcast discussing the Company's 2009 third quarter results on Tuesday, November 10, 2009 at 10:00 a.m. (EST). InterMune, Inc. (Nasdaq:ITMN) announced it has submitted an electronic New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF). Javelin Pharmaceuticals, Inc. (NYSE:JAV) announced its CEO, Martin J. Driscoll, and Stephen J. Tulipano, CFO, will host a conference call to discuss the Company's quarterly results for the period ending September 30, 2009. Lannett Company, Inc. (NYSE:LCI), a manufacturer of generic pharmaceuticals, announced the company will release its fiscal 2010 first-quarter financial results on Monday, November 9, 2009. Unilife Medical Solutions Limited (OTC:UNIFF) (Unilife Australia) entered into a Merger Implementation Agreement with Unilife Corporation (Unilife USA) to facilitate the proposed redomiciliation of the Unilife group in the United States of America (Proposed Transaction). Aeolus Pharmaceuticals, Inc. (OTC:AOLS) reported researchers from National Jewish Health and McGill University have completed a series of preliminary studies demonstrating that AEOL 10150 protects lungs from chlorine gas exposure in mice. Pro-Pharmaceuticals, Inc. (OTC:PRWP) announced it has closed a $310,000 tranche of a private placement of up to $6.0 million with 10X Fund, L.P., which is purchasing unregistered Series B convertible preferred stock and warrants. Affymax, Inc. (Nasdaq:AFFY) and Takeda Pharmaceutical Global Research & Development Center, Inc., announced data from a Phase 2 clinical trial of Hematide™ showing that Hematide increased hemoglobin and reduced or eliminated the need for blood transfusion in most patients with erythropoietin-induced pure red cell aplasia (PRCA). Alkermes, Inc. (NASDAQ:ALKS) announced its corporate presentation will be webcast live by Credit Suisse on Wednesday, November 11, 2009, at 5:00 p.m MT (7:00 p.m. ET) from the Arizona Biltmore Hotel in Phoenix, Arizona. Flamel Technologies (Nasdaq:FLML) expects to release its financial results for the third quarter of 2009 the morning of November 16th, before the market opening. Neurogen Corporation (NASDAQ:NRGN), a drug development company, announced it will release its third quarter 2009 financial results on Friday, November 6, 2009 before the opening of the U.S. financial markets. Santarus, Inc. (NASDAQ:SNTS), a specialty biopharmaceutical company, reported financial and operating results for the quarter ended September 30, 2009. Genta Incorporated (OTC:GETA) announced the Company will release its third quarter 2009 financial results on Monday, November 16, 2009. Gilead Sciences, Inc. (Nasdaq:GILD) announced its corporate presentation will be webcast from the 18th Annual Credit Suisse Healthcare Conference in Phoenix. SurModics, Inc. (Nasdaq:SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, reported financial results for the fourth quarter and fiscal year ended September 30, 2009. - BioMedReports.Com Sy...
Tue, Aug 25, 2009
	(LGND) Ligand Pharmaceuticals to Buy Neurogen Yesterday, Ligand Pharmaceuticals Inc. (LGND) announced it has agreed to purchase Neurogen (NRGN) for $11 million in stock as well as certain future cash payments based on licensing deals, real estate sales and other milestones. The deal, which is expected to close by the fourth quarter of this year, has been approved by both company boards. [...] (LGND) Ligand Pharmaceuticals to Buy Neurogen - Stock Blog Hub
Mon, Aug 24, 2009
	Market Closing: Dow's Narrow Gain Extends Its Rally But S&P, Nasdaq Land In Red Stock averages end narrowly mixed after turning lower as Monday afternoon trading progressed, then chopping in two directions in the final minutes of the session.[More...] - home: iStockAnalyst....
Mon, Mar 17, 2008
	The Greek's Week Ahead - Holy Week! The Greek's Week Ahead is the most comprehensive "week ahead" market-moving event planner in existence. The week ahead will offer a shortened trading period due to Western Christianity’s celebration of Good Friday. Speaking of good Fridays, we have had a few doozies over the past several periods. Two weeks ago, the Employment Situation Report sent markets for a spin, and then last week Bear Stearns needed rescue when it could not find counter-parties willing to deal with it. Thank Benjamin, JP Morgan Chase and the New York Federal Reserve played savior and kept Bear liquid, and solvent for that matter. Unlike Eliot Spitzer, the market was having a relatively decent week until the Bear Stearns emergency. For the week, the Dow closed higher 0.5%, the S&P 500 moved lower 0.4% and the Nasdaq was unchanged. Four-week moving average mutual funds flows continued to show improvement for equity funds, with net inflows averaging $835 million. Still, money funds drew in $18.5 billion in comparison, but this continued a decreasing trend in the level of cash inflow to the sector. Overseas, every major European market closed lower for the week, except Belgium and also Spain on the heels of its election. Finland dropped the most, down 4.0%. The broad DJ STOXX Index fell 1.2%. In Asia, all major markets fell, with the Indonesian market leading the losers as it collapsed 10.6%. India moved 1.2% lower, Japan 4.35% and Hong Kong 3.5%. Gold closed the week just under $1,000 per troy ounce, at $999.50. Light sweet crude closed up $5, to $110.21 per barrel. Natural gas finished higher, to $9.87 per mmbtu. The dollar closed weaker to 1.5665 euros. Before the Bear Stearns blowup... last Friday morning’s Consumer Price Index for February seemed just the right fuel for a strong finish to the week when it offered data showing no change in prices. However, as it turns out, the period recorded completely excluded the recent price rise of oil and distillates, like for instance gasoline! Everyone who drives or has seen a newspaper headline over the past month knows that gasoline has marked record territory recently. So, it appears next month’s CPI will not be so pleasant. As usual, the Fed’s action to keep Bear alive spurred much debate. It smells of a bailout, and that always draws the ire of free market capitalists. There’s a moral hazard to rescuing one company that fails due to its own excessive risk taking. There’s a concern this might encourage haphazard risk management at other firms, since there’s an understanding that the Fed is there for rescue if necessary. However, The Greek disagrees with the moral hazard argument, since we view the alternative unacceptable. If not for this and recent Fed action, we expect the American economy would be well on its way now to depression, not just recession, and that stock prices would be much lower. The Week Ahead This week offers important barometers of manufacturing sector condition and a timely meeting of the Federal Reserve. Monday A new governor takes over in New York and an important area manufacturing barometer will be measured on Monday. The day's Empire State Manufacturing Survey and Industrial Production reports, and the Philadelphia Fed Survey on Thursday, threaten to show manufacturing activity deteriorated. In their last reporting, New York and Philly area manufacturing dropped off sharply. Bloomberg's consensus is looking for a March Empire State General Business Conditions Index level of -6.3. Economists are looking for a February decrease in industrial production of 0.1%, and capacity utilization of 81.3%, which compares to 81.5% in January. Monday’s Treasury International Capital Report will measure foreign demand for long-term U.S. securities in January. December’s data showed a decrease in foreign investment demand from the month just prior. Tuesday’s State Street Investor Confidence Index will show how Americans feel about the same topic. We expect neither group is very optimistic. The Current Account for Q4 is due early Monday morning, while the Housing Market Index for March is set for 1:00 PM release. Monday's most noteworthy earnings reports include Bear Stearns (NYSE: BSC), Conseco (NYSE: CNO), 4Kids Entertainment (NYSE: KDE), AES Corp. (NYSE: AES), Acusphere (Nasdaq: ACUS), Bruker Biosciences (Nasdaq: BRKR), Cosi (Nasdaq: COSI), Excel Maritime Carriers (NYSE: EXM), GeoMet (Nasdaq: GMET), Goldleaf Financial (Nasdaq: GFSI), Houston Wire & Cable (Nasdaq: HWCC), Neurogen (Nasdaq: NRGN), Ocean Power Tech (Nasdaq: OPTT), Perry Ellis (Nasdaq: PERY), Repros Therapeutics (Nasdaq: RPRX), Shuffle Master (Nasdaq: SHFL), Syntroleum (Nasdaq: SYNM), The PMI Group (NYSE: PMI), US BioEnergy (Nasdaq: USBE), Vicor (Nasdaq: VICR) and WCI Communities (NYSE: WCI). Tuesday Le Rogue Trader, Jerome Kerviel might be set free by a Parisian Court on Tuesday. Speaking of criminals, some consider recent Federal Reserve action as highway robbery of dollar value. Heading into last Friday, the treasury market had been forecasting that the Federal Open Market Committee would decide on a 50 basis point rate cut (half of a percentage point) this week. However, in the mayhem of Friday morning, rate cut expectations rose to as high as 100 basis points. More than a handful of economists would rather the Fed not cut rates this time around, considering the further damage it could do to the dollar. There’s well-founded concern that in mitigating recession, the Fed might also spur future inflation that could do even more and longer-lasting economic damage. However, we agree that the Fed has to face the challenge at hand first, before looking beyond to a potential problem. The Fed is hopeful prices will naturally find suppression due to decreased domestic demand for goods and services. Globalization, however, threatens to keep the overall supply/demand equation tight, and thus prices high. We expect the FOMC will cut rates by 50 basis points on Tuesday. The ICSC-UBS Weekly Same-Store Sales results last week surprised on the short side of recent trend. Sales rose only 1.6% last week, year-to-year, while retail sales were reported down 0.6% in February. We estimated that overall sales trends contrasted with same-store sales growth because of mounting store closures and slowing new store openings. Last week's CPI data proved benign, but February's PPI data is due out on Tuesday morning. Bloomberg's survey shows expectations for headline price increase of 0.4% and a Core PPI rise of 0.2%. February Housing Starts are seen measuring 990K, compared to 1.012 million reported in January. The aforementioned State Street Investor Confidence Index is due at 10:00 a.m. Tuesday's earnings reports include Adobe Systems (Nasdaq: ADBE), Darden Restaurants (NYSE: DRI), EnergySolutions (NYSE: ES), Gamestop (NYSE: GME), GenTek (Nasdaq: GETI), Goldman Sachs (NYSE: GS), Healthways (Nasdaq: HWAY), Lehman Brothers (NYSE: LEH), Radyne Corp. (Nasdaq: RADN), Somanetics (Nasdaq: SMTS), Tsakos Energy Navigation (NYSE: TNP) and more. Wednesday Wednesday brings the regular pre-market Mortgage Bankers' Association reporting of weekly mortgage activity. The Fed's action from early last week was partly intended to bring mortgage rates down. We'll see... At 10:30, the EIA's Petroleum Status Report gets yet another opportunity to pound common sense into oil prices, but does supply/demand matter when the valuing currency is losing its worth by the minute. Wednesday earnings reports include China Mobile (NYSE: CHL), General Mills (NYSE: GIS), Morgan Stanley (NYSE: MS), Nike (NYSE: NKE), Avalon Pharmaceuticals (Nasdaq: AVRX), Borders Group (NYSE: BGP), Charming Shoppes (Nasdaq: CHRS), Cintas (Nasdaq: CTAS), CLARCOR (NYSE: CLC), Discover Financial (NYSE: DFS), Emisphere Technologies (Nasdaq: EMIS), Guess (NYSE: GES), Herman Miller (Nasdaq: MLHR), Lindsay Corp. (NYSE: LNN), North American Palladium (AMEX: PAL), Petroleum Development (Nasdaq: PETD), Pinnacle Gas (Nasdaq: PINN), Ross Stores (Nasdaq: ROST), The Marcus Corp. (NYSE: MCS), Ulta Salon, Cosmetics and Fragrance (Nasdaq: ULTA) and more. Thursday Welcome to the witching hour, quadruple witching that is. Weekly Initial Jobless Claims are expected to measure 360K, after sticking at 353K last week. Leading Economic Indicators for February is set for Thursday reporting, and will give some further indication of how likely economic contraction is for the first quarter. Bloomberg's consensus is looking for a 0.3% decrease for February. The Philly Fed Survey, which scared the cheesesteak out of the market last month, is widely expected to sit in negative territory again this time around at -20.0. The EIA Natural Gas Report at 10:30 should again offer bearish data. Thursday's earnings include Carnival Corp. (NYSE: CCL), FedEx (NYSE: FDX), New York & Co. (NYSE: NWY), CRA Int'l (Nasdaq: CRAI), CryoCor (Nasdaq: CRYO), dELiA's(Nasdaq: DLIA), Genpact (NYSE: G), Global Options (Nasdaq: GLOI), Hellenic Telecommunications (NYSE: OTE), Luby's (NYSE: LUB), Palm (Nasdaq: PALM), Progress Software (Nasdaq: PRGS), Shoe Carnival (Nasdaq: SCVL), The Children's Place (Nasdaq: PLCE), Winnebago (NYSE: WGO), WorldSpace (Nasdaq: WRSP), Worthington Industries (NYSE: WOR) and more. Because of the holiday on Friday, U.S. equity and bond markets will be closed. Markets in Hong Kong, Singapore and the U.K. will also be closed. You can support "The Greek" by supporting our advertisers. Thank you. (disclosure) - Wall Street Greek
More Blogs

11/06/09		Q3 2009 Earnings Archive for NRGN
08/14/09		Q2 2009 Earnings Archive for NRGN
05/12/09		Q1 2009 Earnings Archive for NRGN
03/19/09		Q4 2008 Earnings Archive for NRGN
11/07/08		Q3 2008 Earnings Archive for NRGN

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Investing News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs

MoneyWatch.com

About CBS MoneyWatch.com

MoneyWatch.com is the premier destination for smart, practical personal finance advice about your retirement, investing, savings, career and real estate. A joint effort between the news powerhouse CBS and the business experts at BNET, MoneyWatch.com is the place to go for personal financial insight you can trust.

Meet the CBS MoneyWatch.com Team

Feeds

Site Help & Feedback

Beta - Give us your feedback

About CBS MoneyWatch.com

Feeds

Site Help & Feedback

Your Money Be Smarter, Look Younger, Perform Better, and Keep Your Job

Be Smarter, Look Younger, Perform Better, and Keep Your Job

Your Work Four Secrets to Liking Your Work

Four Secrets to Liking Your Work

Your Industry Insights into your industry

Smart Business for Tough Times